Related references
Note: Only part of the references are listed.Systems Pharmacology to Predict Drug Toxicity: Integration Across Levels of Biological Organization
Jane P. F. Bai et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 (2013)
Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorption
M. D. Harwood et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2013)
Excision repair cross-complementing gene-1, ribonucleotide reductase subunit M1, ribonucleotide reductase subunit M2, and human equilibrative nucleoside transporter-1 expression and prognostic value in biliary tract malignancy
Sarah B. Fisher et al.
CANCER (2013)
The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so
Douglas B. Kell et al.
DRUG DISCOVERY TODAY (2013)
Effects of novel neuroprotective and neurorestorative multifunctional drugs on iron chelation and glucose metabolism
Yulia Pollak et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
A community-driven global reconstruction of human metabolism
Ines Thiele et al.
NATURE BIOTECHNOLOGY (2013)
Genetics and iron in the systems biology of Parkinson's disease and some related disorders
Claudia Funke et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
The road from systems biology to systems medicine
Olaf Wolkenhauer et al.
PEDIATRIC RESEARCH (2013)
Structure and dynamics of molecular networks: A novel paradigm of drug discovery A comprehensive review
Peter Csermely et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Oral drug delivery utilizing intestinal OATP transporters
Ikumi Tamai
ADVANCED DRUG DELIVERY REVIEWS (2012)
Human Equilibrative Nucleoside Transporter 1 Expression Predicts Survival of Advanced Cholangiocarcinoma Patients Treated With Gemcitabine-Based Adjuvant Chemotherapy After Surgical Resection
Hironori Kobayashi et al.
ANNALS OF SURGERY (2012)
Immunohistochemical Analysis of Human Equilibrative Nucleoside Transporter-1 (hENT1) Predicts Survival in Resected Pancreatic Cancer Patients Treated with Adjuvant Gemcitabine Monotherapy
Soichiro Morinaga et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Novel Computational Approaches to Polypharmacology as a Means to Define Responses to Individual Drugs
Lei Xie et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
Systems Pharmacology: Network Analysis to Identify Multiscale Mechanisms of Drug Action
Shan Zhao et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
The Expression and Function of Organic Anion Transporting Polypeptides in Normal Tissues and in Cancer
Amanda Obaidat et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
Drug Transporters in Drug Efficacy and Toxicity
M. K. DeGorter et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
Towards Safer and More Predictable Drug Treatment - Reflections from Studies of the First BCPT Prize Awardee
Pertti J. Neuvonen
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2012)
The prototypic pharmacogenetic drug debrisoquine is a substrate of the genetically polymorphic organic cation transporter OCT1
Ali R. Saadatmand et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Scientific discovery as a combinatorial optimisation problem: How best to navigate the landscape of possible experiments?
Douglas B. Kell
BIOESSAYS (2012)
Softening the Rule of Five-where to draw the line?
Joachim Petit et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Metabolic network modeling and simulation for drug targeting and discovery
Hyun Uk Kim et al.
BIOTECHNOLOGY JOURNAL (2012)
Natural product-likeness score revisited: an open-source, open-data implementation
Kalai Vanii Jayaseelan et al.
BMC BIOINFORMATICS (2012)
Improving metabolic flux predictions using absolute gene expression data
Dave Lee et al.
BMC SYSTEMS BIOLOGY (2012)
Interaction of innovative small molecule drugs used for cancer therapy with drug transporters
K. Mandery et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies
Megan Roth et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Drug Trafficking: Recent Advances in Therapeutics and Disease
J. A. Sprowl et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Transporter-Mediated Drug-Drug Interactions Involving OATP Substrates: Predictions Based on In Vitro Inhibition Studies
K. Yoshida et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Computational Modeling to Accelerate the Identification of Substrates and Inhibitors for Transporters That Affect Drug Disposition
S. Ekins et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Prediction of Transporter-Mediated Drug-Drug Interactions Using Endogenous Compounds
M. F. Fromm
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Zebrafish as a Model to Study Drug Transporters at the Blood-Brain Barrier
R. A. Umans et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
The UCSF-FDA TransPortal: A Public Drug Transporter Database
K. M. Morrissey et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Physiologically Based Pharmacokinetics Joined With In Vitro-In Vivo Extrapolation of ADME: A Marriage Under the Arch of Systems Pharmacology
A. Rostami-Hodjegan
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Highlights from the International Transporter Consortium Second Workshop
M. J. Zamek-Gliszczynski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Phenotypic Screening Strategies for Neurodegenerative Diseases: A Pathway to Discover Novel Drug Candidates and Potential Disease Targets or Mechanisms
R. M. Pruss
CNS & Neurological Disorders-Drug Targets (2012)
The promise and challenge of personalized medicine: aging populations, complex diseases, and unmet medical need
Adriano M. Henney
CROATIAN MEDICAL JOURNAL (2012)
Sodium Dependent Multivitamin Transporter (SMVT): A Potential Target for Drug Delivery
Aswani Dutt Vadlapudi et al.
CURRENT DRUG TARGETS (2012)
Ladostigil: A Novel Multimodal Neuroprotective Drug with Cholinesterase and Brain-Selective Monoamine Oxidase Inhibitory Activities for Alzheimer's Disease Treatment
Orly Weinreb et al.
CURRENT DRUG TARGETS (2012)
Statins as Anti-Inflammatory Agents in Atherogenesis: Molecular Mechanisms and Lessons from the Recent Clinical Trials
Alexios S. Antonopoulos et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Expanding the medicinally relevant chemical space with compound libraries
Fabian Lopez-Vallejo et al.
DRUG DISCOVERY TODAY (2012)
Can we discover pharmacological promiscuity early in the drug discovery process?
Jens-Uwe Peters et al.
DRUG DISCOVERY TODAY (2012)
Relevance of systems pharmacology in drug discovery
Lourdes Cucurull-Sanchez et al.
DRUG DISCOVERY TODAY (2012)
Genetic Polymorphisms of OATP Transporters and Their Impact on Intestinal Absorption and Hepatic Disposition of Drugs
Takeo Nakanishi et al.
DRUG METABOLISM AND PHARMACOKINETICS (2012)
Contribution of tumoral and host solute carriers to clinical drug response
Jason A. Sprowl et al.
DRUG RESISTANCE UPDATES (2012)
Human equilibrative nucleoside transporter 1 (hENT1) expression is a potential predictive tool for response to gemcitabine in patients with advanced cholangiocarcinoma
I. Borbath et al.
EUROPEAN JOURNAL OF CANCER (2012)
Identifying and characterizing promiscuous targets: Implications for virtual screening
Violeta I. Perez-Nueno et al.
EXPERT OPINION ON DRUG DISCOVERY (2012)
Environmental chemicals as substrates, inhibitors or inducers of drug transporters: implication for toxicokinetics, toxicity and pharmacokinetics
Olivier Fardel et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)
Genetics or environment in drug transport: the case of organic anion transporting polypeptides and adverse drug reactions
John D. Clarke et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)
Novel models for assessing blood-brain barrier drug permeation
Werner J. Geldenhuys et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)
Fluoroquinolone disposition: identification of the contribution of renal secretory and reabsorptive drug transporters
Aditi Mulgaonkar et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)
Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development
Yurong Lai et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)
Pharmacogenomics of adverse drug reactions: implementing personalized medicine
Chun-Yu Wei et al.
HUMAN MOLECULAR GENETICS (2012)
Physiological and Pharmacological Roles of Vascular Nucleoside Transporters
Rachel W. S. Li et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2012)
Drug Effect Prediction by Polypharmacology-Based Interaction Profiling
Zoltan Simon et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Human equilibrative nucleoside transporter 1 expression is a strong independent prognostic factor in UICC T3-T4 pancreatic cancer patients treated with preoperative gemcitabine-based chemoradiotherapy
Yasuhiro Murata et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2012)
Using the reconstructed genome-scale human metabolic network to study physiology and pathology
A. Bordbar et al.
JOURNAL OF INTERNAL MEDICINE (2012)
Systems medicine and metabolic modelling
A. Mardinoglu et al.
JOURNAL OF INTERNAL MEDICINE (2012)
Implications of Promiscuous Pim-1 Kinase Fragment Inhibitor Hydrophobic Interactions for Fragment-Based Drug Design
Andrew C. Good et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Classification of Inhibitors of Hepatic Organic Anion Transporting Polypeptides (OATPs): Influence of Protein Expression on Drug - Drug Interactions
Maria Karlgren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
The reconstruction and analysis of tissue specific human metabolic networks
Tong Hao et al.
MOLECULAR BIOSYSTEMS (2012)
Model-driven multi-omic data analysis elucidates metabolic immunomodulators of macrophage activation
Aarash Bordbar et al.
MOLECULAR SYSTEMS BIOLOGY (2012)
Chemical genetic discovery of targets and anti-targets for cancer polypharmacology
Arvin C. Dar et al.
NATURE (2012)
Automated design of ligands to polypharmacological profiles
Jeremy Besnard et al.
NATURE (2012)
Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML
Georg E. Winter et al.
NATURE CHEMICAL BIOLOGY (2012)
Systems metabolic engineering of microorganisms for natural and non-natural chemicals
Jeong Wook Lee et al.
NATURE CHEMICAL BIOLOGY (2012)
Quantifying the chemical beauty of drugs
G. Richard Bickerton et al.
NATURE CHEMISTRY (2012)
Finding the sweet spot: the role of nature and nurture in medicinal chemistry
Michael M. Hann et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Neuroprotection by the multitarget iron chelator M30 on age-related alterations in mice
Lana Kupershmidt et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2012)
A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory
Leroy Hood et al.
NEW BIOTECHNOLOGY (2012)
Organic Anion and Cation SLC22 Drug'' Transporter (Oat1, Oat3, and Oct1) Regulation during Development and Maturation of the Kidney Proximal Tubule
Thomas F. Gallegos et al.
PLOS ONE (2012)
Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions
Manthena V. S. Varma et al.
PHARMACEUTICAL RESEARCH (2012)
Systems biology analysis of protein-drug interactions
Jacques Colinge et al.
PROTEOMICS CLINICAL APPLICATIONS (2012)
Fragment-based lead design
Olga A. Tarasova et al.
RUSSIAN CHEMICAL REVIEWS (2012)
The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase
Simon A. Hawley et al.
SCIENCE (2012)
Concise Review: A High-Content Screening Approach to Stem Cell Research and Drug Discovery
Xiaofeng Xia et al.
STEM CELLS (2012)
Epistemic and methodological iteration in scientific research
Kevin C. Elliott
STUDIES IN HISTORY AND PHILOSOPHY OF SCIENCE (2012)
Functions of OATP1A and 1B transporters in vivo: insights from mouse models
Dilek Iusuf et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
A comparative analysis of the molecular topologies for drugs, clinical candidates, natural products, human metabolites and general bioactive compounds
Hongming Chen et al.
MEDCHEMCOMM (2012)
Virtual Cell: computational tools for modeling in cell biology
Diana C. Resasco et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2012)
The virtual liver: a multidisciplinary, multilevel challenge for systems biology
Hermann-Georg Holzhuetter et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2012)
Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine
Elliott Antman et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2012)
RNAi screening: new approaches, understandings, and organisms
Stephanie E. Mohr et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2012)
Ten Challenges for Systems Medicine
Enrico Capobianco
Frontiers in Genetics (2012)
In Vitro Evaluation of Hepatic Transporter-Mediated Clinical Drug-Drug Interactions: Hepatocyte Model Optimization and Retrospective Investigation
Yi-an Bi et al.
DRUG METABOLISM AND DISPOSITION (2012)
Organic cation transporters in the blood-air barrier: expression and implications for pulmonary drug delivery
Johanna Jessica Salomon et al.
THERAPEUTIC DELIVERY (2012)
Human Metabolic Network: Reconstruction, Simulation, and Applications in Systems Biology
Ming Wu et al.
METABOLITES (2012)
The Blood-Testis Barrier and Its Implications for Male Contraception
C. Yan Cheng et al.
PHARMACOLOGICAL REVIEWS (2012)
Systems pharmacology of complex diseases
Jens Hansen et al.
ANIMAL MODELS: THEIR VALUE IN PREDICTING DRUG EFFICACY AND TOXICITY (2011)
Strategies to Discover Unexpected Targets for Drugs Active at G Protein-Coupled Receptors
John A. Allen et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011 (2011)
Metabolites as global regulators: A new view of protein regulation
Xiyan Li et al.
BIOESSAYS (2011)
The prognostic significance of human equilibrative nucleoside transporter 1 expression in patients with metastatic bladder cancer treated with gemcitabine-cisplatin-based combination chemotherapy
Nagahide Matsumura et al.
BJU INTERNATIONAL (2011)
Genome-wide assessment of the carriers involved in the cellular uptake of drugs: a model system in yeast
Karin Lanthaler et al.
BMC BIOLOGY (2011)
A Systems Biology Strategy for Predicting Similarities and Differences of Drug Effects: Evidence for Drug-specific Modulation of Inflammation in Atherosclerosis
Robert Kleemann et al.
BMC SYSTEMS BIOLOGY (2011)
Parameter estimation in systems biology models using spline approximation
Choujun Zhan et al.
BMC SYSTEMS BIOLOGY (2011)
A community effort towards a knowledge-base and mathematical model of the human pathogen Salmonella Typhimurium LT2
Ines Thiele et al.
BMC SYSTEMS BIOLOGY (2011)
Integration of Genotypic and Phenotypic Screening Reveals Molecular Mediators of Melanoma-Stromal Interaction
Megan J. Stine et al.
CANCER RESEARCH (2011)
Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety
Nicholas A. Meanwell
CHEMICAL RESEARCH IN TOXICOLOGY (2011)
Compound Prioritization Methods Increase Rates of Chemical Probe Discovery in Model Organisms
Iain M. Wallace et al.
CHEMISTRY & BIOLOGY (2011)
Revisiting the Rule of Five on the Basis of Pharmacokinetic Data from Rat
Lars Ridder et al.
CHEMMEDCHEM (2011)
Linking Pharmacology to Clinical Reports: Cyclobenzaprine and Its Possible Association With Serotonin Syndrome
J. Mestres et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Transporter-Mediated Drug Uptake and Efflux: Important Determinants of Adverse Drug Reactions
O. Zolk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Human Equilibrative Nucleoside Transporter 1 (hENT1) Levels Predict Response to Gemcitabine in Patients With Biliary Tract Cancer (BTC)
D. Santini et al.
CURRENT CANCER DRUG TARGETS (2011)
Mechanisms for the anti-inflammatory effects of statins
De-xiu Bu et al.
CURRENT OPINION IN LIPIDOLOGY (2011)
Structure-based systems biology for analyzing off-target binding
Lei Xie et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2011)
Synthetic and Natural Products as Iron Chelators
Philip C. Sharpe et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development
Balaji M. Agoram et al.
DRUG DISCOVERY TODAY (2011)
Evolution of the physicochemical properties of marketed drugs: can history foretell the future?
Bernard Faller et al.
DRUG DISCOVERY TODAY (2011)
Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only
Douglas B. Kell et al.
DRUG DISCOVERY TODAY (2011)
Tissue Distribution and Characterization of Drug-Related Material in Rats and Dogs after Repeated Oral Administration of Casopitant
Sabrina Pagliarusco et al.
DRUG METABOLISM AND DISPOSITION (2011)
2D MI-DRAGON: A new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins
Francisco Prado-Prado et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Mapping of pharmacological space
Britta Nisius et al.
EXPERT OPINION ON DRUG DISCOVERY (2011)
Drug and metabolite concentrations in tissues in relationship to tissue adverse findings: a review
Mario Pellegatti et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2011)
Long evolutionary conservation and considerable tissue specificity of several atypical solute carrier transporters
Smitha Sreedharan et al.
GENE (2011)
High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome
Sam Alsford et al.
GENOME RESEARCH (2011)
The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma
Sarah K. Johnson et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
Looking to the Future: Biomarkers in the Management of Pancreatic Adenocarcinoma
Jennifer L. Spratlin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Strategies for bringing drug delivery tools into discovery
Elizabeth Kwong et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Using Consensus-Shape Clustering To Identify Promiscuous Ligands and Protein Targets and To Choose the Right Query for Shape-Based Virtual Screening
Violeta I. Perez-Nueno et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6
Nicola Baker et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2011)
Genome-wide RNAi screens in bloodstream form trypanosomes identify drug transporters
Gabriela Schumann Burkard et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2011)
In Silico Target Profiling of One Billion Molecules
Alfons Nonell-Canals et al.
MOLECULAR INFORMATICS (2011)
Ligand Efficiency Indices (LEIs): More than a Simple Efficiency Yardstick
Cele Abad-Zapatero et al.
MOLECULAR INFORMATICS (2011)
Associating Drugs, Targets and Clinical Outcomes into an Integrated Network Affords a New Platform for Computer-Aided Drug Repurposing
Tudor I. Oprea et al.
MOLECULAR INFORMATICS (2011)
SYSTEMS BIOLOGY Metabolites do social networking
Douglas B. Kell
NATURE CHEMICAL BIOLOGY (2011)
Navigating the kinome
James T. Metz et al.
NATURE CHEMICAL BIOLOGY (2011)
Efficient discovery of anti-inflammatory small-molecule combinations using evolutionary computing
Ben G. Small et al.
NATURE CHEMICAL BIOLOGY (2011)
How were new medicines discovered?
David C. Swinney et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
The influence of the 'organizational factor' on compound quality in drug discovery
Paul D. Leeson et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Probing the links between in vitro potency, ADMET and physicochemical parameters
M. Paul Gleeson et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
From zero to hero-Design-based systems metabolic engineering of Corynebacterium glutamicum for L-lysine production
Judith Becker et al.
METABOLIC ENGINEERING (2011)
Mining metabolites: extracting the yeast metabolome from the literature
Chikashi Nobata et al.
METABOLOMICS (2011)
NOVEL MOLECULAR TARGETS OF THE NEUROPROTECTIVE/NEURORESCUE MULTIMODAL IRON CHELATING DRUG M30 IN THE MOUSE BRAIN
L. Kupershmidt et al.
NEUROSCIENCE (2011)
ChemProt: a disease chemical biology database
Olivier Taboureau et al.
NUCLEIC ACIDS RESEARCH (2011)
PROMISCUOUS: a database for network-based drug-repositioning
Joachim von Eichborn et al.
NUCLEIC ACIDS RESEARCH (2011)
Understanding and Classifying Metabolite Space and Metabolite-Likeness
Julio E. Peironcely et al.
PLOS ONE (2011)
Systems Pharmacology: Bridging Systems Biology and Pharmacokinetics-Pharmacodynamics (PKPD) in Drug Discovery and Development
Piet H. van der Graaf et al.
PHARMACEUTICAL RESEARCH (2011)
Systems metabolic engineering for chemicals and materials
Jeong Wook Lee et al.
TRENDS IN BIOTECHNOLOGY (2011)
Impact of ion class and time on oral drug molecular properties
Paul D. Leeson et al.
MEDCHEMCOMM (2011)
Molecular obesity, potency and other addictions in drug discovery
Michael M. Hann
MEDCHEMCOMM (2011)
Role of systems pharmacology in understanding drug adverse events
Seth I. Berger et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2011)
Chemical-protein Interactome and Its Application in Off-target Identification
Lun Yang et al.
INTERDISCIPLINARY SCIENCES-COMPUTATIONAL LIFE SCIENCES (2011)
Comparison of Multivariate Data Analysis Strategies for High-Content Screening
Anne Kuemmel et al.
JOURNAL OF BIOMOLECULAR SCREENING (2011)
The beautiful cell: high-content screening in drug discovery
Marc Bickle
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2010)
Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples
Douglas B. Kell
ARCHIVES OF TOXICOLOGY (2010)
The Chemical Basis of Pharmacology
Michael J. Keiser et al.
BIOCHEMISTRY (2010)
iPHACE: integrative navigation in pharmacological space
Ricard Garcia-Serna et al.
BIOINFORMATICS (2010)
Compartmentalization of the Edinburgh Human Metabolic Network
Tong Hao et al.
BMC BIOINFORMATICS (2010)
Properties of the Proximate Parameter Tuning Regularization Algorithm
Martin Brown et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2010)
Gemcitabine Metabolic and Transporter Gene Polymorphisms Are Associated With Drug Toxicity and Efficacy in Patients With Locally Advanced Pancreatic Cancer
Motofumi Tanaka et al.
CANCER (2010)
Anti-inflammatory Agents: Present and Future
Charles A. Dinarello
CELL (2010)
Extensive In Vivo Metabolite-Protein Interactions Revealed by Large-Scale Systematic Analyses
Xiyan Li et al.
CELL (2010)
Next-Generation Model-Based Drug Discovery and Development: Quantitative and Systems Pharmacology
S. R. B. Allerheiligen
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Dissecting Variability in Responses to Cancer Chemotherapy Through Systems Pharmacology
R. Yang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Rational approaches to targeted polypharmacology: creating and navigating protein-ligand interaction networks
James T. Metz et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
Expanding the range of 'druggable' targets with natural product-based libraries: an academic perspective
Renato A. Bauer et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
Kinetics of iron oxidation upon polyphenol binding
Nathan R. Perron et al.
DALTON TRANSACTIONS (2010)
High-content screening for the discovery of pharmacological compounds: advantages, challenges and potential benefits of recent technological developments
Emmanuelle Soleilhac et al.
EXPERT OPINION ON DRUG DISCOVERY (2010)
Lipophilicity in drug discovery
Michael J. Waring
EXPERT OPINION ON DRUG DISCOVERY (2010)
Anticipating drug side effects by comparative pharmacology
Ricard Garcia-Serna et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2010)
Model-Free Drug-Likeness from Fragments
Oleg Ursu et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
Polypharmacology Directed Compound Data Mining: Identification of Promiscuous Chemotypes with Different Activity Profiles and Comparison to Approved Drugs
Ye Hu et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
Application of physiologically based pharmacokinetic modeling and clearance concept to drugs showing transporter-mediated distribution and clearance in humans
Takao Watanabe et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2010)
From structure to dynamics: Frequency tuning in the p53-Mdm2 network. II Differential and stochastic approaches
Djomangan A. Ouattara et al.
JOURNAL OF THEORETICAL BIOLOGY (2010)
Reconstruction annotation jamborees: a community approach to systems biology
Ines Thiele et al.
MOLECULAR SYSTEMS BIOLOGY (2010)
HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology
Christoph Gille et al.
MOLECULAR SYSTEMS BIOLOGY (2010)
Insight into human alveolar macrophage and M. tuberculosis interactions via metabolic reconstructions
Aarash Bordbar et al.
MOLECULAR SYSTEMS BIOLOGY (2010)
Fishing for neuroactive compounds
Jeremy L. Jenkins et al.
NATURE CHEMICAL BIOLOGY (2010)
A predictive model for drug bioaccumulation and bioactivity in Caenorhabditis elegans
Andrew R. Burns et al.
NATURE CHEMICAL BIOLOGY (2010)
Rapid behavior-based identification of neuroactive small molecules in the zebrafish
David Kokel et al.
NATURE CHEMICAL BIOLOGY (2010)
Natural products in modern life science
Lars Bohlin et al.
PHYTOCHEMISTRY REVIEWS (2010)
Chemical genetics approach to identify new small molecule modulators of cell growth by phenotypic screening of Saccharomyces cerevisiae strains with a library of morpholine-derived compounds
Andrea Trabocchi et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2010)
Anti-Inflammatory Effects of Resveratrol, Curcumin and Simvastatin in Acute Small Intestinal Inflammation
Stefan Bereswill et al.
PLOS ONE (2010)
Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice
Alessio Squassina et al.
PHARMACOGENOMICS (2010)
Fourier analysis and systems identification of the p53 feedback loop
Naama Geva-Zatorsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles
Paul A. Clemons et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Population robustness arising from cellular heterogeneity
Pawel Paszek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Zebrafish Behavioral Profiling Links Drugs to Biological Targets and Rest/Wake Regulation
Jason Rihel et al.
SCIENCE (2010)
Inferring Signaling Pathway Topologies from Multiple Perturbation Measurements of Specific Biochemical Species
Tian-Rui Xu et al.
SCIENCE SIGNALING (2010)
Small Molecule Screening in Zebrafish
David S. Peal et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2010)
Interdependence of Gemcitabine Treatment, Transporter Expression, and Resistance in Human Pancreatic Carcinoma Cells
Wolfgang Hagmann et al.
NEOPLASIA (2010)
Fragment-Based Screening by Biochemical Assays: Systematic Feasibility Studies with Trypsin and MMP12
Andreas Boettcher et al.
JOURNAL OF BIOMOLECULAR SCREENING (2010)
High-Content Screening: A Decade of Evolution
Nick Thomas
JOURNAL OF BIOMOLECULAR SCREENING (2010)
Effects of Drug Transporters on Volume of Distribution
Anita Grover et al.
AAPS JOURNAL (2009)
Mass spectrometry tools and metabolite-specific databases for molecular identification in metabolomics
M. Brown et al.
ANALYST (2009)
Network analyses in systems pharmacology
Seth I. Berger et al.
BIOINFORMATICS (2009)
Siderophore production by marine-derived fungi
Brian Holinsworth et al.
BIOMETALS (2009)
Physiochemical property space distribution among human metabolites, drugs and toxins
Varun Khanna et al.
BMC BIOINFORMATICS (2009)
Automated genome mining for natural products
Michael H. T. Li et al.
BMC BIOINFORMATICS (2009)
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases
Douglas B. Kell
BMC MEDICAL GENOMICS (2009)
A Review of the Antioxidant Mechanisms of Polyphenol Compounds Related to Iron Binding
Nathan R. Perron et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2009)
Pharmacological Promiscuity: Dependence on Compound Properties and Target Specificity in a Set of Recent Roche Compounds
Jens-Uwe Peters et al.
CHEMMEDCHEM (2009)
Human Equilibrative Nucleoside Transporter 1 and Human Concentrative Nucleoside Transporter 3 Predict Survival after Adjuvant Gemcitabine Therapy in Resected Pancreatic Adenocarcinoma
Raphael Marechal et al.
CLINICAL CANCER RESEARCH (2009)
Applications of High Content Screening in Life Science Research
Joseph M. Zock
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2009)
Exploring the chemical space of microbial natural products
Hiroyuki Osada et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2009)
Implications of the Dominant Role of Transporters in Drug Uptake by Cells
Paul D. Dobson et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
Automation in High-Content Flow Cytometry Screening
U. Naumann et al.
CYTOMETRY PART A (2009)
Revealing promiscuous drug-target interactions by chemical proteomics
Marcus Bantscheff et al.
DRUG DISCOVERY TODAY (2009)
'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries
Paul D. Dobson et al.
DRUG DISCOVERY TODAY (2009)
Role of membrane transporters in the safety profile of drugs
Edmund Jon Deoon Lee et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Identification of interspecies difference in hepatobiliary transporters to improve extrapolation of human biliary secretion
Yurong Lai
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Physicochemical drug properties associated with in vivo toxicological outcomes: a review
David A. Price et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer
James J. Farrell et al.
GASTROENTEROLOGY (2009)
Chemoinformatic Analysis of Combinatorial Libraries, Drugs, Natural Products, and Molecular Libraries Small Molecule Repository
Narender Singh et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Novel Chemical Space Exploration via Natural Products
Josefin Rosen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
From structure to dynamics: Frequency tuning in the p53-Mdm2 network I. Logical approach
Wassim Abou-Jaoude et al.
JOURNAL OF THEORETICAL BIOLOGY (2009)
Predicting the multi-modal binding propensity of small molecules: towards an understanding of drug promiscuity
Keunwan Park et al.
MOLECULAR BIOSYSTEMS (2009)
The topology of drug-target interaction networks: implicit dependence on drug properties and target families
Jordi Mestres et al.
MOLECULAR BIOSYSTEMS (2009)
Molecular Pharmacology of Promiscuous Seven Transmembrane Receptors Sensing Organic Nutrients
Petrine Wellendorph et al.
MOLECULAR PHARMACOLOGY (2009)
Rapid and sustained nuclear-cytoplasmic ERK oscillations induced by epidermal growth factor
Harish Shankaran et al.
MOLECULAR SYSTEMS BIOLOGY (2009)
Applications of genome-scale metabolic reconstructions
Matthew A. Oberhardt et al.
MOLECULAR SYSTEMS BIOLOGY (2009)
DRUG DISCOVERY Predicting promiscuity
Andrew L. Hopkins
NATURE (2009)
Predicting new molecular targets for known drugs
Michael J. Keiser et al.
NATURE (2009)
Synergistic drug combinations tend to improve therapeutically relevant selectivity
Joseph Lehar et al.
NATURE BIOTECHNOLOGY (2009)
A proteomics approach to discovering natural products and their biosynthetic pathways
Stefanie B. Bumpus et al.
NATURE BIOTECHNOLOGY (2009)
Bioactivity-guided mapping and navigation of chemical space
Steffen Renner et al.
NATURE CHEMICAL BIOLOGY (2009)
HMDB: a knowledgebase for the human metabolome
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2009)
Fulfilling the Promise of Personalized Medicine? Systematic Review and Field Synopsis of Pharmacogenetic Studies
Michael V. Holmes et al.
PLOS ONE (2009)
Unfaithful neurotransmitter transporters: Focus on serotonin uptake and implications for antidepressant efficacy
Lynette C. Daws
PHARMACOLOGY & THERAPEUTICS (2009)
Pulsatile Stimulation Determines Timing and Specificity of NF-κB-Dependent Transcription
Louise Ashall et al.
SCIENCE (2009)
Drug Discovery and Natural Products: End of an Era or an Endless Frontier?
Jesse W. -H. Li et al.
SCIENCE (2009)
Update on statin-mediated anti-inflammatory activities in atherosclerosis
Fabrizio Montecucco et al.
SEMINARS IN IMMUNOPATHOLOGY (2009)
The Application of Phenotypic High-Throughput Screening Techniques to Cardiovascular Research
Yoram Etzion et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2009)
Conciliating binding efficiency and polypharmacology
Jordi Mestres et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Systems pharmacology and genome medicine: a future perspective
Aislyn D. Wist et al.
GENOME MEDICINE (2009)
Systems medicine: the future of medical genomics and healthcare
Charles Auffray et al.
GENOME MEDICINE (2009)
Identification of a Topological Characteristic Responsible for the Biological Robustness of Regulatory Networks
Yangle Wu et al.
PLOS COMPUTATIONAL BIOLOGY (2009)
A Mapping of Drug Space from the Viewpoint of Small Molecule Metabolism
James Corey Adams et al.
PLOS COMPUTATIONAL BIOLOGY (2009)
Drug Discovery for Schistosomiasis: Hit and Lead Compounds Identified in a Library of Known Drugs by Medium-Throughput Phenotypic Screening
Maha-Hamadien Abdulla et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
Immunomodulatory and Anti-Inflammatory Activities of Statins
Emilia Mira et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2009)
Natural products as a robust source of new drugs and drug leads: Past successes and present day issues
Gilbert M. Rishton
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Adenoviral-mediated overexpression of human equilibrative nucleoside transporter 1 (hENT1) enhances gemcitabine response in human pancreatic cancer
Sandra Perez-Torras et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Genetic screening for novel Drosophila mutants with discrepancies in iron metabolism
Anuja Mehta et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
BioBayes: A software package for Bayesian inference in systems biology
Vladislav Vyshemirsky et al.
BIOINFORMATICS (2008)
Bayesian inference of the sites of perturbations in metabolic pathways via Markov chain Monte Carlo
Bayu Jayawardhana et al.
BIOINFORMATICS (2008)
Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity
Gavin A. Whitlock et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
The state of innovation in drug development
I. Kola
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
A ligand-based approach to mining the chemogenomic space of drugs
Elisabet Gregori-Puigjane et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2008)
Sloppiness, robustness, and evolvability in systems biology
Bryan C. Daniels et al.
CURRENT OPINION IN BIOTECHNOLOGY (2008)
The impact of natural products upon modern drug discovery
A. Ganesan
CURRENT OPINION IN CHEMICAL BIOLOGY (2008)
Human metabolic network reconstruction and its impact on drug discovery and development
Hongwu Ma et al.
DRUG DISCOVERY TODAY (2008)
Natural products in drug discovery
Alan L. Harvey
DRUG DISCOVERY TODAY (2008)
Interindividual variability in oral antidiabetic drug disposition and response: the role of drug transporter polymorphisms
Michael A. Pacanowski et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Natural product-likeness score and its application for prioritization of compound libraries
Peter Ertl et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2008)
Genome mining for novel natural product discovery
Gregory L. Challis
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Proximate parameter tuning for biochemical networks with uncertain kinetic parameters
Stephen J. Wilkinson et al.
MOLECULAR BIOSYSTEMS (2008)
High-order combination effects and biological robustness
Joseph Lehar et al.
MOLECULAR SYSTEMS BIOLOGY (2008)
Scaffold diversity of natural products: inspiration for combinatorial library design
Kristina Grabowski et al.
NATURAL PRODUCT REPORTS (2008)
Natural products to drugs: natural product-derived compounds in clinical trials
Mark S. Butler
NATURAL PRODUCT REPORTS (2008)
A network solution
Adriano Henney et al.
NATURE (2008)
Frequency-modulated nuclear localization bursts coordinate gene regulation
Long Cai et al.
NATURE (2008)
Large-scale chemical dissection of mitochondrial function
Bridget K. Wagner et al.
NATURE BIOTECHNOLOGY (2008)
A quantitative analysis of kinase inhibitor selectivity
Mazen W. Karaman et al.
NATURE BIOTECHNOLOGY (2008)
A consensus yeast metabolic network reconstruction obtained from a community approach to systems biology
Markus J. Herrgard et al.
NATURE BIOTECHNOLOGY (2008)
Chemical biology and the limits of reductionism
Randall T. Peterson
NATURE CHEMICAL BIOLOGY (2008)
Network pharmacology: the next paradigm in drug discovery
Andrew L. Hopkins
NATURE CHEMICAL BIOLOGY (2008)
Opinion - Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
Paul D. Dobson et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The virtual physiological human: building a framework for computational biomedicine
Gordon Clapworthy et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES (2008)
Patient-specific simulation as a basis for clinical decision-making
S. Kashif Sadiq et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES (2008)
Protein area occupancy at the center of the red blood cell membrane
Allison D. Dupuy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Drug target identification using side-effect similarity
Monica Campillos et al.
SCIENCE (2008)
Caenorhabditis elegans:: An emerging model in biomedical and environmental toxicology
Maxwell C. K. Leung et al.
TOXICOLOGICAL SCIENCES (2008)
Application of systems biology for bioprocess development
Jin Hwan Park et al.
TRENDS IN BIOTECHNOLOGY (2008)
Role of transport proteins in drug discovery and development: a pharmaceutical perspective
A. Ayrton et al.
XENOBIOTICA (2008)
Fragment-based approach to drug lead discovery - Overview and advances in various techniques
Daniela Fattori et al.
DRUGS IN R&D (2008)
Metabolite profiles of interacting mycelial fronts differ for pairings of the wood decay basidiomycete fungus, Stereum hirsutum with its competitors Coprinus micaceus and Coprinus disseminatus
Diluka Peiris et al.
METABOLOMICS (2008)
Bayesian ranking of biochemical system models
Vladislav Vyshemirsky et al.
BIOINFORMATICS (2008)
Integrating high-content screening and ligand-target prediction to identify mechanism of action
Daniel W. Young et al.
NATURE CHEMICAL BIOLOGY (2008)
Accurate automated log Po/w measurement by gradient-flow liquid-liquid partition chromatography Part 1.: Neutral compounds
Sandrine Demare et al.
JOURNAL OF CHROMATOGRAPHY A (2007)
Drug discovery beyond the 'rule-of-five'
Ming-Qiang Zhang et al.
CURRENT OPINION IN BIOTECHNOLOGY (2007)
A Sorcerer's apprentice and the rule of five: from rule-of-thumb to commandment and beyond
Cele Abad-Zapatero
DRUG DISCOVERY TODAY (2007)
The influence of drug-like concepts on decision-making in medicinal chemistry
Paul D. Leeson et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
The absence of human equilibrative nucleoside transporter 1 expression predicts nonresponse to gemcitabine-containing chemotherapy in non-small cell lung cancer
Tetsuya Oguri et al.
CANCER LETTERS (2007)
Drug-target network
Muhammed A. Yildirim et al.
NATURE BIOTECHNOLOGY (2007)
The Edinburgh human metabolic network reconstruction and its functional analysis
Hongwu Ma et al.
MOLECULAR SYSTEMS BIOLOGY (2007)
Metabolite essentiality elucidates robustness of Escherichia coli metabolism
Pan-Jun Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A comparison of the chemical properties of drugs and FEMA/FDA notified GRAS chemical compounds used in the food industry
D. G. Sprous et al.
FOOD AND CHEMICAL TOXICOLOGY (2007)
Ultradian oscillations of Stat, Smad, and Hes1 expression in response to serum
Shigeki Yoshiura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Automated reverse engineering of nonlinear dynamical systems
Josh Bongard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Modeling promiscuity based on in vitro safety pharmacology profiling data
Kamal Azzaoui et al.
CHEMMEDCHEM (2007)
Metabolic engineering of Escherichia coli for the production of L-valine based on transcriptome analysis and in silico gene knockout simulation
Jin Hwan Park et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells
Y. Nakano et al.
BRITISH JOURNAL OF CANCER (2007)
Global reconstruction of the human metabolic network based on genomic and bibliomic data
Natalie C. Duarte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Fragments, network biology and designing multiple ligands
Richard Morphy et al.
DRUG DISCOVERY TODAY (2007)
Relating protein pharmacology by ligand chemistry
Michael J. Keiser et al.
NATURE BIOTECHNOLOGY (2007)
Comparing the chemical spaces of metabolites and available chemicals: models of metabolite-likeness
Sunil Gupta et al.
MOLECULAR DIVERSITY (2007)
Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox
Scott A. Becker et al.
NATURE PROTOCOLS (2007)
The value of natural products to future pharmaceutical discovery
Dwight D. Baker et al.
NATURAL PRODUCT REPORTS (2007)
Fragment-based drug discovery: What has it achieved so fair?
Alexander A. Alex et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
Natural products as sources of new drugs over the last 25 years
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2007)
Oscillations and temporal signalling in cells
G. Tiana et al.
PHYSICAL BIOLOGY (2007)
Lead-like, drug-like or pub-like: how different are they?
Tudor I. Oprea et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2007)
Multi-target therapeutics: when the whole is greater than the sum of the parts
Grant R. Zimmermann et al.
DRUG DISCOVERY TODAY (2007)
A decade of fragment-based drug design: strategic advances and lessons learned
Philip J. Hajduk et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Innovation - A robustness-based approach to systems-oriented drug design
Hiroaki Kitano
NATURE REVIEWS DRUG DISCOVERY (2007)
Systems biology, metabolic modelling and metabolomics in drug discovery and development
Douglas B. Kell
DRUG DISCOVERY TODAY (2006)
Statistical strategies for avoiding false discoveries in metabolomics and related experiments
David I. Broadhurst et al.
METABOLOMICS (2006)
Pharmacology of delayed aging and extended lifespan of Caenorhabditis elegans
James J. Collins et al.
EXPERIMENTAL GERONTOLOGY (2006)
Fragment screening: an introduction
Andrew R. Leach et al.
MOLECULAR BIOSYSTEMS (2006)
Global mapping of pharmacological space
Gaia V. Paolini et al.
NATURE BIOTECHNOLOGY (2006)
TarFisDock: a web server for identifying drug targets with docking approach
Honglin Li et al.
NUCLEIC ACIDS RESEARCH (2006)
Dependence of molecular properties on proteomic family for marketed oral drugs
Michal Vieth et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Single-cell proteomic analysis of S-cerevisiae reveals the architecture of biological noise
John R. S. Newman et al.
NATURE (2006)
Drug and bile acid transporters in rosuvastatin hepatic uptake: Function, expression, and pharmacogenetics
Richard H. Ho et al.
GASTROENTEROLOGY (2006)
Transporters as a determinant of drug clearance and tissue distribution
Y Shitara et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine
E Giovannetti et al.
CANCER RESEARCH (2006)
Metabolomics, modelling and machine learning in systems biology - towards an understanding of the languages of cells
DB Kell
FEBS JOURNAL (2006)
Can we rationally design promiscuous drugs?
AL Hopkins et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2006)
High-throughput screening of small molecules for bioactivity and target identification in Caenorhabditis elegans
Andrew R. Burns et al.
NATURE PROTOCOLS (2006)
Oscillations and variability in the p53 system
Naama Geva-Zatorsky et al.
MOLECULAR SYSTEMS BIOLOGY (2006)
Drug discovery from natural sources
Young-Won Chin et al.
AAPS JOURNAL (2006)
Visualization and interpretation of high content screening data
A Smellie et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2006)
Systems biology, connectivity and the future of medicine
J van der Greef
IEE PROCEEDINGS SYSTEMS BIOLOGY (2005)
Innovation -: Rescuing drug discovery:: in vivo systems pathology and systems pharmacology
J van der Greef et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Metabolomics reviewed: A new Omics platform technology for systems biology and implications for natural products research
S Rochfort
JOURNAL OF NATURAL PRODUCTS (2005)
Analysis of drug-induced effect patterns to link structure and side effects of medicines
AF Fliri et al.
NATURE CHEMICAL BIOLOGY (2005)
Identifying biologically active compound classes using phenotypic screening data and sampling statistics
J Klekota et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2005)
Systems cell biology knowledge created from high content screening
KA Giuliano et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2005)
Fast determination of lipophilicity by HPLC
L Ayouni et al.
CHROMATOGRAPHIA (2005)
Synergistic control of oscillations in the NF-κB signalling pathway
AEC Ihekwaba et al.
IEE PROCEEDINGS SYSTEMS BIOLOGY (2005)
Nonlinear system identification using coevolution of models and tests
JC Bongard et al.
IEEE TRANSACTIONS ON EVOLUTIONARY COMPUTATION (2005)
Expanding the ChemGPS chemical space with natural products
J Larsson et al.
JOURNAL OF NATURAL PRODUCTS (2005)
High content screening for G protein-coupled receptors using cell-based protein translocation assays
C Grånäs et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2005)
Changes in the transcriptional profile of transporters in the intestine along the anterior-posterior and crypt-villus axes
P Anderle et al.
BMC GENOMICS (2005)
Finding the target after screening the phenotype
CP Hart
DRUG DISCOVERY TODAY (2005)
Robustness, evolvability, and neutrality
A Wagner
FEBS LETTERS (2005)
Protein families and their evolution - A structural perspective
CA Orengo et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2005)
Predicting drug disposition via application of BCS: Transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system
CY Wu et al.
PHARMACEUTICAL RESEARCH (2005)
High-content screening and profiling of drug activity in an automated centrosome-duplication assay
ZE Perlman et al.
CHEMBIOCHEM (2005)
Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia
BL Roth et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
A new accident model for engineering safer systems
N Leveson
SAFETY SCIENCE (2004)
Predicting undesirable drug interactions with promiscuous proteins in silico
S Ekins
DRUG DISCOVERY TODAY (2004)
Dynamics of the p53-Mdm2 feedback loop in individual cells
G Lahav et al.
NATURE GENETICS (2004)
Chemogenomic profiling: Identifying the functional interactions of small molecules in yeast
G Giaever et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Robustness of cellular functions
J Stelling et al.
CELL (2004)
Fragment-based lead discovery
DC Rees et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Flow cytometry for high-throughput, high-content screening
BS Edwards et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2004)
RNAi living-cell microarrays for loss-of-function screens in Drosophila melanogaster cells
DB Wheeler et al.
NATURE METHODS (2004)
Oscillations in NF-κB signaling control the dynamics of gene expression
DE Nelson et al.
SCIENCE (2004)
The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma
J Spratlin et al.
CLINICAL CANCER RESEARCH (2004)
Complex phenotypic assays in high-throughput screening
PA Clemons
CURRENT OPINION IN CHEMICAL BIOLOGY (2004)
High content screening applied to large-scale cell biology
VC Abraham et al.
TRENDS IN BIOTECHNOLOGY (2004)
Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era
DB Kell et al.
BIOESSAYS (2004)
Global analysis of protein expression in yeast
S Ghaemmaghami et al.
NATURE (2003)
Advances in high content screening for drug discovery
KA Giuliano et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2003)
Metabolic pathways in the post-genome era
JA Papin et al.
TRENDS IN BIOCHEMICAL SCIENCES (2003)
Property distributions: Differences between drugs, natural products, and molecules from combinatorial chemistry
M Feher et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2003)
Stabilization of atherosclerotic plaques: New mechanisms and clinical targets
P Libby et al.
NATURE MEDICINE (2002)
Robustness as a measure of plausibility in models of biochemical networks
M Morohashi et al.
JOURNAL OF THEORETICAL BIOLOGY (2002)
Prediction of 'drug-likeness'
WP Walters et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening
CM Grozinger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
High content screening - from cells to data to knowledge
C Liptrot
DRUG DISCOVERY TODAY (2001)
Robustness as an evolutionary principle
S Bornholdt et al.
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2000)
Small molecule developmental screens reveal the logic and timing of vertebrate development
RT Peterson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
The segment polarity network is a robust developmental module
G von Dassow et al.
NATURE (2000)
De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks
G Schneider et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2000)
Share Paper
